|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 14-05-06 | Actavis : Factbox - M&A frenzy transforming global pharma | RE |
| 14-05-06 | Actavis : M&A frenzy in healthcare sector | RE |
Company details: Forest Laboratories, Inc.
Forest Laboratories, Inc.
909 Third Avenue
10022-4731, New York
+212-421-7850
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | +5.13% | +58.93% | +117.36% | 1,133B | |
| -0.61% | +1.52% | +34.34% | +68.48% | 621B | |
| -1.48% | +0.47% | +23.08% | +94.76% | 503B | |
| -1.22% | +2.40% | +38.61% | +63.67% | 379B | |
| +1.07% | +1.70% | +71.06% | +45.98% | 370B | |
| +0.74% | +1.60% | +21.99% | +51.38% | 292B | |
| +0.08% | -0.39% | +0.86% | +25.23% | 262B | |
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | |
| -1.88% | +0.02% | +23.77% | +97.39% | 190B | |
| Average | -0.24% | +3.22% | +35.36% | +69.05% | 443.11B | |
| Weighted average by Cap. | +0.03% | +3.73% | +40.77% | +79.75% |
- Stock Market
- Stocks
- Stock
- Company Forest Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
